Diagnostics (Sep 2023)

Citrullination Post-Translational Modification: State of the Art of Brain Tumor Investigations and Future Perspectives

  • Diana Valeria Rossetti,
  • Alexandra Muntiu,
  • Luca Massimi,
  • Gianpiero Tamburrini,
  • Claudia Desiderio

DOI
https://doi.org/10.3390/diagnostics13182872
Journal volume & issue
Vol. 13, no. 18
p. 2872

Abstract

Read online

The present review aims to describe the state of the art of research studies investigating the citrullination post-translational modification in adult and pediatric brain tumors. After an introduction to the deimination reaction and its occurrence in proteins and polypeptide chains, the role of the citrullination post-translational modification in physiological as well as pathological states, including cancer, is summarized, and the recent literature and review papers on the topic are examined. A separate section deals with the specific focus of investigation of the citrullination post-translational modification in relation to brain tumors, examining the state of the art of the literature that mainly concerns adult and pediatric glioblastoma and posterior fossa pediatric tumors. We examined the literature on this emerging field of research, and we apologize in advance for any possible omission. Although only a few studies inspecting citrullination in brain tumors are currently available, the results interestingly highlighted different profiles of the citrullinome associated with different histotypes. The data outlined the importance of this post-translational modification in modulating cancer invasion and chemoresistance, influencing key factors involved in apoptosis, cancer cell communication through extracellular vesicle release, autophagy, and gene expression processes, which suggests the prospect of taking citrullination as a target of cancer treatment or as a source of potential diagnostic and prognostic biomarkers for potential clinical applications in the future.

Keywords